Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema

Conclusion: UWFFA-guided TRP reduced the number of injections of Ranibizumab in patients having BRVO with macular edema, while maintaining similar benefits in the improvement of BCVA, central subfoveal thickness without deleterious effect on the visual field, and contrast sensitivity.

Source: Indian Journal of Ophthalmology - June 24, 2019 Category: Opthalmology Authors: Siddhi Goel Atul Kumar Raghav D Ravani Parijat Chandra Mahesh Chandra Vinod Kumar Source Type: research